0001209191-21-047105.txt : 20210719
0001209191-21-047105.hdr.sgml : 20210719
20210719142718
ACCESSION NUMBER: 0001209191-21-047105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210714
FILED AS OF DATE: 20210719
DATE AS OF CHANGE: 20210719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIMARD JOHN
CENTRAL INDEX KEY: 0001639078
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37347
FILM NUMBER: 211097639
MAIL ADDRESS:
STREET 1: 8201 E RIVERSIDE DRIVE
STREET 2: BLDG 4, STE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XBiotech Inc.
CENTRAL INDEX KEY: 0001626878
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8201 E. RIVERSIDE DRIVE
STREET 2: BUILDING 4, SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
BUSINESS PHONE: 512-386-2930
MAIL ADDRESS:
STREET 1: 8201 E. RIVERSIDE DRIVE
STREET 2: BUILDING 4, SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-14
0
0001626878
XBiotech Inc.
XBIT
0001639078
SIMARD JOHN
5217 WINNEBAGO LANE
AUSTIN
TX
78744
1
1
1
0
Chief Executive Officer
Common Stock
2021-07-14
4
S
0
50000
18.147
D
4173166
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Effective June 2021, John Simard, CEO Chairman of XBiotech, Inc., adopted a stock trading plan. He sold 50,000 common stock on the open market as part of this 10B5-1 trading plan.
/s/ Queena Han under Power of Attorney for John Simard
2021-07-19